.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Merck
Johnson and Johnson
Dow
Covington
US Department of Justice
UBS
QuintilesIMS
Medtronic
Citi

Generated: February 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0217493.6

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-001May 29, 2009ABRXYesNo➤ Sign Up➤ Sign UpY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-002May 29, 2009ABRXYesYes➤ Sign Up➤ Sign UpY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-003May 29, 2009ABRXYesNo➤ Sign Up➤ Sign UpY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-004May 29, 2009ABRXYesYes➤ Sign Up➤ Sign UpY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-005Apr 14, 2010ABRXYesNo➤ Sign Up➤ Sign UpY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-006Jun 21, 2011ABRXYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist